DCM
STIM icon

Driehaus Capital Management’s Neuronetics STIM Stock Holding History

Driehaus Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100,000
Closed -$486K – 464
2020
Q3 		$486K Buy
+100,000
New +$379K 0.01% 335
2018
Q4 		– Sell
-217,135
Closed -$6.96M – 514
2018
Q3 		$6.96M Sell
217,135
-46,698
-18% -$1.42M 0.21% 144
2018
Q2 		$7.02M Buy
+263,833
New +$7.17M 0.24% 132

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Driehaus Capital Management's STIM Position: Q4 2020 in Review

Driehaus Capital Management sold out of Neuronetics (STIM) in Q4 2020, closing a stake of 100,000 shares — an estimated $486K sold.

Driehaus Capital Management first reported a position in STIM in Q2 2018 and held it in 3 quarters. The position peaked at $7.02M in Q2 2018. 61 funds tracked by Wall St. Rank hold STIM as of Q4 2020.

  • Driehaus Capital Management reported no remaining Neuronetics position as of Q4 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 100,000 Neuronetics shares in Q4 2020, an estimated $486K.
  • Driehaus Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 3 quarters.
  • Driehaus Capital Management's Neuronetics position peaked at $7.02M in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Neuronetics as of Q4 2020.

Based on Driehaus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.